Critical Care Infectious Diseases

 

WEBINAR SERIES

Critical Care Infectious Diseases – Hot Topics and Upcoming Trends

Organised by the ISAC Infections in the ICU & Sepsis Working Group, ESCMID Study Group for Infections in Critically Ill Patients (ESGCIP) and King's Critical Care, King's College Hospital London.

Session2: MDR infections in the ICU: antibiotics, duration and immune modulation

11 December 2025 @ 10.00

PROGRAMME

• New antibiotics for tackling MDR Gram-Negative Infections in the ICU
  Matteo Bassetti, Italy
• Old antibiotics in a new era: rescue therapies for MBL-GNBs
  Demosthenes Makris, Greece
• Duration of antibiotic therapy for severe infection in critically ill patients: how long is long enough?
  Jean-Francois Timsit, France
• Immune modulation in critical illness: reframing hospital-acquired pneumonia treatment through the host lens
  Antoine Roquilly, France

-----------------------------------------

Session 1: Optimising Antimicrobial Therapy in Critical Care: From Levels to Outcomes

24 November 2025 @ 10.00 CET - ON DEMAND COMING SOON

Join us for the first in a three-part webinar series exploring cutting-edge developments in critical care infectious diseases. This session focuses on precision approaches to antibiotic use and monitoring, featuring global experts sharing the latest insights and clinical implications.

Moderators: Despoina Koulenti (UK) & Hakan Erdem (Turkey)

PROGRAMME

• Practising Precisely: Optimising Antibiotics
  Jason Roberts (Australia)
• TDM Monitoring in Critical Care: Study Updates and Future Precision Dosing
  Mohd Hafiz Abdul-Aziz (Australia)
• Beta-lactams Toxicity: Still an Under-recognised Matter?
  Claire Roger (France)
• Global Perspectives on Continuous Beta-Lactam Infusion: Implementation Challenges and Clinical Insights
  Reena Mehta (United Kingdom)

---------------------------------

Session 3:

20 January 2026

PROGRAMME

• Relevance of CMV and HSV detection in BAL of critically ill patients
  Stefan Hagel, Germany
• Severe GAS infections: Emerging insights and therapeutic frontiers
  Phil Hopkins, United Kingdom
• Sepsis in the ICU beyond the temperate zone: diagnostic complexities in tropical Illness
  Yash Javeri, India
• Dual defence: infection control and antibiotic stewardship in the ICU frontline
  Emine Alp, Turkey

 

REGISTRATION OPENING SOON

----------------------------------

SPEAKER BIOS

Prof. Matteo Bassetti is Chief of the Infectious Disease Division at Ospedale Policlinico San Martino, Genoa, and Full Professor at the University of Genoa. He also directs the School of Specialisation in Infectious and Tropical Diseases, the Regional Inter-company Department for Infectious Diseases (Liguria), and the Genoa Metropolitan Department of Infectious Diseases. Prof. Bassetti has held leadership roles in major international societies, including Chair of the ESCMID Critically Ill Study Group, President of the Italian Society of Anti-infective Therapy (SITA), and member of the International Sepsis Forum. He serves on national committees for antimicrobial resistance and infection control. Editorially, he contributes to journals such as Intensive Care Medicine and Journal of Global Antimicrobial Resistance. With over 1,000 peer-reviewed publications (H-index: 122, >60,000 citations), his research spans antimicrobial resistance, infections in critically ill and immunocompromised patients, and antibiotic therapy.

Prof. Demosthenes A. Makris is Director of the Critical Care Department at University Hospital of Larissa and Professor of Critical Care Medicine at the University of Thessaly, Greece. He holds an MD from Aristotle University of Thessaloniki and a PhD from the University of Crete, with advanced training in critical care and interventional pulmonology in the UK and France. His research focuses on ICU infections, respiratory failure, COPD and interventional pulmonology, and he has authored over 150 peer-reviewed publications. Prof. Makris is actively involved in national scientific societies, postgraduate education, and clinical leadership, maintaining a strong academic and clinical presence in respiratory and critical care medicine.

Prof. Jean-François Timsit is a Professor of Intensive Care Medicine at AP-HP Bichat Hospital and University Paris-Cité where he heads the Medical and Infectious Diseases ICU (MI2). He holds a PhD in epidemiology and public health and accreditation to supervise research (HDR). He leads the OUTCOME-REA research network and serves as Research Officer for ESGCIP within ESCMID. His research focuses on sepsis, antimicrobial therapy, multidrug resistance, catheter-related infections, ventilator-associated pneumonia and quality improvement in critical care. He has supervised numerous masters and PhD theses, chaired the infection section of ESICM and coordinated critical care research for ESCMID. With an h-index of 97 and over 700 publications, he is recognised internationally for contributions to infection control, prognostic modelling and high-quality clinical databases.

Prof. Antoine Roquilly is based at Nantes Université and CHU Nantes, where he works within the Center for Research in Transplantation and Translational Immunology (UMR 1064) and the Service of Anesthesiology and Critical Care (CIC 1413). He also holds an affiliation with the Department of Microbiology and Immunology at The University of Melbourne, Doherty Institute. His research focuses on immuno-infectiology and host-pathogen interactions, particularly in pneumonia. He coordinates major European projects, including HAP2 (Host-targeted approaches for pneumonia) under Horizon 2020 and Homi-Lung (Host-microbiome interactions and long-term outcomes after pneumonia) under Horizon Europe, reflecting leadership in translational research and international collaboration.

Dr Despoina Koulenti, MD, PhD, is a Consultant in Critical Care at King’s College Hospital, London, and Visiting Professor in Greece. She is currently Secretary of ESGCIP of ESCMID and Treasurer of ISAC's Working Group on ICU Infections and Sepsis.
She holds a PhD in ICU pneumonia and completed postdoctoral research in critical care infections at The University of Queensland. Her research focuses on ICU infections, sepsis, MDR pathogens, and antimicrobial stewardship. She has authored over 130 publications (h-index 50) and serves as Associate Editor of Intensive and Critical Care Nursing. She is active in ISAC, ESCMID, ESICM, and national health bodies, contributing to research, education, and expert committees globally.

Prof. Hakan Erdem, MD, is an Infectious Diseases and Clinical Microbiology Specialist and lead coordinator of ID-IRI, a major global clinical research platform. He is a Professor at Gülhane School of Medicine, Ankara, Türkiye, with extensive experience in ICU and community-acquired infections, clinical teaching, and international research. He is active in ESCMID and its study groups (ESGIB, ESGITM, ESGCIP). He received the ESCMID Fellow title in 2017 and ID-IRI Fellow in 2024 for distinguished contributions. He has authored numerous publications (h-index 45) and leads multicenter research initiatives. ORCID: 0000-0002-6265-5227.

Prof. Claire Roger, MD, PhD, leads three ICUs at Nimes University Hospital and teaches at the University of Montpellier. Her research focuses on antimicrobial pharmacokinetics, dose optimization in critically ill patients, and therapeutic drug monitoring. She has led major international cohorts on infectious diseases and published over 150 peer-reviewed articles. She serves on the Editorial Board of the European Journal of Anesthesiology and is active in ESICM (SIS, Infection Section, Academy Subcommittee) and ESCMID (EPASG, ESGCIP). She co-authored French beta-lactam optimization guidelines and contributes to the Executive Scientific Committee of the French Anesthesiology and Intensive Care Society.

Reena Mehta, MPharm, MSc, is a Consultant Pharmacist in Critical Care at King’s College Hospital, London, and Chair of the UK Intensive Care Society’s Learning Division. With over 15 years’ experience, her expertise includes antimicrobial stewardship, medicines in extracorporeal circuits, and health inequalities. She contributes nationally to pharmacy workforce development, clinical guidelines, and advanced training. Reena is an Associate Editor for the Journal of the Intensive Care Society, Honorary Senior Lecturer at King’s College London, and Principal Investigator on CRN Portfolio studies. She also leads pharmacy for South East London ICS Critical Care/ODN and recently completed an MSc at LSE.

Prof. Jason Roberts is Director of the University of Queensland Centre for Clinical Research and an NHMRC Leadership Fellow. He is also a Consultant Clinical Pharmacist at the Royal Brisbane and Women’s Hospital and Interim Director of the Herston Infectious Diseases Institute. A leading clinician-scientist, his research focuses on optimizing antimicrobial dosing in critically ill patients. Prof Roberts has authored over 650 publications, secured more than $55 million in research funding, and supervised over 20 PhD students. Recognized as Australia’s top researcher in Critical Care and Communicable Diseases, he contributes to international guidelines and advances global infectious disease management.

Dr Mohd Hafiz Abdul-Aziz is a Clinical Research Pharmacist and Early Career Research Fellow at the University of Queensland Centre for Clinical Research. He leads the Clinical Dosing Studies and Knowledge Translation Workstream within the Antimicrobial Optimisation Group and CRE RESPOND. His research focuses on optimizing antimicrobial dosing in critically ill patients, including those on ECMO and renal replacement therapy. Dr Abdul-Aziz has authored over 80 peer-reviewed publications, with more than 4,800 citations, and coordinates multi-national pharmacokinetic studies such as ASAP ECMO and BLING 3. He is a Fellow of ISAC and chairs its Infections in the ICU and Sepsis Working Group.